Free Trial
LON:APH

Alliance Pharma (APH) Share Price, News & Analysis

Alliance Pharma logo

About Alliance Pharma Stock (LON:APH)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
64.70
64.70
52-Week Range
N/A
Volume
N/A
Average Volume
5.95 million shs
Market Capitalization
£350.32 million
P/E Ratio
N/A
Dividend Yield
3.75%
Price Target
GBX 6,250
Consensus Rating
Hold

Company Overview

Alliance Pharma Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
38th Percentile Overall Score

APH MarketRank™: 

Alliance Pharma scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Alliance Pharma has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Upside Potential

    Alliance Pharma has a consensus price target of GBX 6,250, representing about ∞ upside from its current price of GBX 0.

  • Amount of Analyst Coverage

    Alliance Pharma has received no research coverage in the past 90 days.

  • Read more about Alliance Pharma's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Alliance Pharma is -10.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Alliance Pharma is -10.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Alliance Pharma has a PEG Ratio of 1.04. PEG Ratios around 1 indicate that a company is correctly valued.

  • Short Interest

    There is no current short interest data available for APH.
  • Dividend Leadership

    Alliance Pharma is a leading dividend payer. It pays a dividend yield of 3.75%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Alliance Pharma does not have a long track record of dividend growth.

  • Read more about Alliance Pharma's dividend.
  • Short Interest

    There is no current short interest data available for APH.
  • Search Interest

    53 people have searched for APH on MarketBeat in the last 30 days. This is an increase of 47% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Alliance Pharma insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    11.95% of the stock of Alliance Pharma is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    66.34% of the stock of Alliance Pharma is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Alliance Pharma's insider trading history.
Receive APH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Alliance Pharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APH Stock News Headlines

RBC Capital Reaffirms Their Hold Rating on Alliance Pharma (APH)
Reagan’s former tech advisor sharing bombshell announcement
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
Alliance Pharma Regulatory News
See More Headlines

APH Stock Analysis - Frequently Asked Questions

Alliance Pharma plc (LON:APH) released its earnings results on Tuesday, April, 8th. The company reported $4.32 earnings per share (EPS) for the quarter. Alliance Pharma had a negative net margin of 18.34% and a negative trailing twelve-month return on equity of 15.24%.

Shares of APH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Alliance Pharma investors own include boohoo group (BOO), BP (BP), Vodafone Group Public (VOD), Aviva (AV), Babcock International Group (BAB), BAE Systems (BA) and The Gym Group (GYM).

Company Calendar

Last Earnings
4/08/2025
Today
9/13/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Electronic Equipment
Current Symbol
LON:APH
CIK
N/A
Fax
N/A
Employees
91,000
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 6,250
Low Price Target
GBX 6,250
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (6.20)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
1.04
Net Income
-£33.65 million
Net Margins
-18.34%
Pretax Margin
N/A
Return on Equity
-15.24%
Return on Assets
5.98%

Debt

Debt-to-Equity Ratio
46.27
Current Ratio
2.93
Quick Ratio
1.42

Sales & Book Value

Annual Sales
£183.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
7.87
Book Value
GBX 41.25 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
541,444,969
Free Float
N/A
Market Cap
£350.32 million
Optionable
Not Optionable
Beta
0.67
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:APH) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners